Jacques Fourgeaud
Overview
Explore the profile of Jacques Fourgeaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
792
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veyrenche N, Fourgeaud J, Burgard M, Allali S, Toubiana J, Pinhas Y, et al.
J Infect
. 2025 Jan;
90(2):106409.
PMID: 39761699
Background: A Parvovirus B19 (B19V) outbreak has been reported in Europe in 2023-2024. The aims of this study were 1) to describe the incidence of primary cases from 2012 to...
2.
Riller Q, Schmutz M, Fourgeaud J, Fischer A, Neven B
Immunol Rev
. 2024 Sep;
328(1):243-264.
PMID: 39340232
Enteric viruses are the main cause of acute gastroenteritis worldwide with a significant morbidity and mortality, especially among children and aged adults. Some enteric viruses also cause disseminated infections and...
3.
Bourgon N, Lopez R, Fourgeaud J, Guilleminot T, Bussieres L, Magny J, et al.
J Antimicrob Chemother
. 2024 Aug;
79(10):2500-2508.
PMID: 39087737
Background: The treatment of congenital cytomegalovirus (CMV) infection is usually administered to neonates after birth; however, it can be anticipated during the prenatal period by treating pregnant women in order...
4.
Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N, et al.
Lancet Reg Health Eur
. 2024 Jul;
42:100974.
PMID: 39050231
[This corrects the article DOI: 10.1016/j.lanepe.2024.100892.].
5.
Momenilandi M, Levy R, Sobrino S, Li J, Lagresle-Peyrou C, Esmaeilzadeh H, et al.
Cell
. 2024 May;
187(11):2817-2837.e31.
PMID: 38701783
FMS-related tyrosine kinase 3 ligand (FLT3L), encoded by FLT3LG, is a hematopoietic factor essential for the development of natural killer (NK) cells, B cells, and dendritic cells (DCs) in mice....
6.
Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N, et al.
Lancet Reg Health Eur
. 2024 Apr;
40:100892.
PMID: 38590940
Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0.64% global prevalence and a 17-20% chance of serious long-term effects in children. Since the last guidelines, our understanding, particularly...
7.
Fourgeaud J, Magny J, Couderc S, Garcia P, Maillotte A, Benard M, et al.
Pediatrics
. 2024 Mar;
153(4).
PMID: 38487823
Background: Approximately 20% of neonates with congenital cytomegalovirus (cCMV) develop long-term sequelae. The ability to accurately predict long-term outcomes as early as the neonatal period would help to provide for...
8.
Fourgeaud J, Regnault B, Ok V, Da Rocha N, Sitterle E, Mekouar M, et al.
Lancet Microbe
. 2023 Dec;
5(1):e52-e61.
PMID: 38048804
Background: Metagenomic next-generation sequencing (mNGS) allows untargeted identification of a broad range of pathogens, including rare or novel microorganisms. Despite the recognition of mNGS as a valuable diagnostic tool for...
9.
Fourgeaud J, Nguyen C, Guilleminot T, Ville Y, Leruez-Ville M
J Clin Virol
. 2023 Nov;
169:105614.
PMID: 37982548
Introduction: CMV serology screening in the first trimester pregnancy is based on IgG and IgM testing followed by IgG avidity in cases with positive IgM. However, the sensitivity of this...
10.
Fourgeaud J, Allali S, Toubiana J, Pinhas Y, Frange P, Leruez-Ville M, et al.
J Clin Virol
. 2023 Aug;
167:105576.
PMID: 37633184
No abstract available.